NO2022054I1 - olipudase alfa - Google Patents

olipudase alfa

Info

Publication number: NO2022054I1
Authority: NO; Norway
Prior art keywords: olipudase alfa; olipudase; alfa
Prior art date: 2009-08-28

Application number

NO2022054C

Other languages

English (en)

Original Assignee

Icahn School Med Mount Sinai

Genzyme Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-08-28

Filing date

2022-12-01

Publication date

2022-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43625265&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2022054(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2022-12-01 Application filed by Icahn School Med Mount Sinai, Genzyme Corp filed Critical Icahn School Med Mount Sinai

2022-12-01 Publication of NO2022054I1 publication Critical patent/NO2022054I1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Dermatology (AREA)

NO2022054C 2009-08-28 2022-12-01 olipudase alfa NO2022054I1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US23811309P	2009-08-28	2009-08-28

Publications (1)

Publication Number	Publication Date
NO2022054I1 true NO2022054I1 (no)	2022-12-01

Family

ID=43625265

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO2022054C NO2022054I1 (no)	2009-08-28	2022-12-01	olipudase alfa

Country Status (27)

Country	Link
US (9)	US8349319B2 (no)
EP (3)	EP3998078A1 (no)
JP (7)	JP5955219B2 (no)
KR (5)	KR20230164773A (no)
CN (3)	CN106047835A (no)
AU (5)	AU2010286550B2 (no)
BR (1)	BR112012004377A2 (no)
CA (1)	CA2773133A1 (no)
CL (1)	CL2012000495A1 (no)
CY (1)	CY1122128T1 (no)
DK (2)	DK2470199T3 (no)
ES (2)	ES2902229T3 (no)
FR (1)	FR22C1062I2 (no)
HR (2)	HRP20211992T1 (no)
HU (3)	HUE046598T2 (no)
IL (4)	IL300625B1 (no)
LT (2)	LT3482767T (no)
MX (1)	MX356873B (no)
NL (1)	NL301211I2 (no)
NO (1)	NO2022054I1 (no)
PL (2)	PL2470199T3 (no)
PT (2)	PT2470199T (no)
RU (3)	RU2569744C2 (no)
SI (2)	SI3482767T1 (no)
TR (1)	TR201911293T4 (no)
WO (1)	WO2011025996A2 (no)
ZA (2)	ZA201201435B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8889127B2 (en)	2004-07-01	2014-11-18	Icahn School Of Medicine At Mount Sinai	Targeted protein replacement for the treatment of lysosomal storage disorders
US20080228056A1 (en)	2007-03-13	2008-09-18	Michael Blomquist	Basal rate testing using frequent blood glucose input
US7751907B2 (en)	2007-05-24	2010-07-06	Smiths Medical Asd, Inc.	Expert system for insulin pump therapy
US8221345B2 (en)	2007-05-30	2012-07-17	Smiths Medical Asd, Inc.	Insulin pump based expert system
PT2158322T (pt)	2007-06-06	2017-08-09	Genzyme Corp	Terapia genética para doenças do armazenamento lisossomal
PL2470199T3 (pl) *	2009-08-28	2019-11-29	Icahn School Med Mount Sinai	Enzymatyczna terapia zastępcza ze zwiększaniem dawki do leczenia niedoboru kwaśnej sfingomielinazy
US8882701B2 (en) *	2009-12-04	2014-11-11	Smiths Medical Asd, Inc.	Advanced step therapy delivery for an ambulatory infusion pump and system
WO2011146143A2 (en)	2010-05-21	2011-11-24	Ohmx Corporation	Detection of cancer by assaying psa enzymatic activity
JP6117708B2 (ja)	2011-03-18	2017-04-19	ジェンザイム・コーポレーション	グルコシルセラミド合成酵素阻害剤
PL2753346T3 (pl)	2011-09-07	2020-10-19	Mount Sinai School Of Medicine	Ceramidaza i różnicowanie komórek
DK2780716T3 (da)	2011-11-15	2019-10-14	Centogene Ag	Fremgangsmåde til diagnose af Niemann-Pick sygdom
ES2786128T3 (es)	2012-06-01	2020-10-08	Icahn School Med Mount Sinai	Niveles de ceramida en el tratamiento y prevención de infecciones
MA37975B2 (fr)	2012-09-11	2021-03-31	Genzyme Corp	Inhibiteurs de synthase de glucosylcéramide
MX2015012471A (es)	2013-03-14	2016-08-03	Icahn School Med Mount Sinai	Composiciones terapéuticas de ceramidasa ácida y métodos para prepararlas y utilizarlas.
JO3713B1 (ar)	2013-03-15	2021-01-31	Genzyme Corp	أشكال ملح (s)-كوينوكليدين-3-يل(2-(2-(4-فلوروفينيل)ثيازول-4-يل)بروبان-2-يل)كارباميت
DK2997384T3 (da) *	2013-05-14	2019-07-22	Centogene Ag	Fremgangsmåde til diagnose af niemann-pick sygdom
US10022428B2 (en) *	2013-06-07	2018-07-17	Genzyme Corporation	Marker for acid sphingomyelinase disorders and uses thereof
JP6984854B2 (ja) *	2015-10-08	2021-12-22	国立大学法人千葉大学	ニーマン・ピック病ｃ型を予防または治療するための医薬組成物
US10569016B2 (en)	2015-12-29	2020-02-25	Tandem Diabetes Care, Inc.	System and method for switching between closed loop and open loop control of an ambulatory infusion pump
BR112020003541A2 (pt)	2017-08-24	2020-09-01	Sanofi	tratamento de condições ósseas anormais em pacientes com deficiência de esfingomielinase ácida
MA50746A (fr)	2017-10-02	2020-08-12	Denali Therapeutics Inc	Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive
UY38238A (es)	2018-05-25	2019-12-31	Genzyme Corp	Composiciones farmacéuticas para el tratamiento de la deficiencia de esfingomielinasa ácida
TW202142236A (zh)	2020-02-03	2021-11-16	美商健臻公司	用於治療與溶體儲積症相關的神經症狀之方法
US11857512B2 (en)	2020-07-24	2024-01-02	Genzyme Corporation	Pharmaceutical compositions comprising venglustat

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4039388A (en)	1976-06-04	1977-08-02	The United States Of America As Represented By The Government	Diagnostic test for Niemann-Pick disease
US4082781A (en)	1976-06-04	1978-04-04	The United States Of America As Represented By The Department Of Health, Education And Welfare	Synthesis of 2-alkanoylamino-4-nitrophenyl phosphorylcholine-hydroxide
IL74761A0 (en)	1984-04-13	1985-06-30	Hughes Howard Med Inst	Human phenylalanine hydroxylase cdna clones,their production and their use in diagnosing classical phenylketonuria
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4863195A (en) *	1987-10-02	1989-09-05	Capozzola Carl A	Identification tag
US5047335A (en)	1988-12-21	1991-09-10	The Regents Of The University Of Calif.	Process for controlling intracellular glycosylation of proteins
US5549892A (en)	1988-12-23	1996-08-27	Genzyme Corporation	Enhanced in vivo uptake of glucocerebrosidase
US5773278A (en)	1991-05-03	1998-06-30	Mount Sinai Medical Center	Acid sphingomyelinase gene
US6034298A (en)	1991-08-26	2000-03-07	Prodigene, Inc.	Vaccines expressed in plants
US5612487A (en)	1991-08-26	1997-03-18	Edible Vaccines, Inc.	Anti-viral vaccines expressed in plants
US5484719A (en)	1991-08-26	1996-01-16	Edible Vaccines, Inc.	Vaccines produced and administered through edible plants
US5641670A (en)	1991-11-05	1997-06-24	Transkaryotic Therapies, Inc.	Protein production and protein delivery
US5716614A (en)	1994-08-05	1998-02-10	Molecular/Structural Biotechnologies, Inc.	Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
EP0865499B1 (en)	1995-09-14	2009-03-18	Virginia Tech Intellectual Properties, Inc.	Production of lysosomal enzymes in plant-based expression systems
JP2820106B2 (ja)	1996-02-29	1998-11-05	日本電気株式会社	トラヒックシェーパ装置
US20050032211A1 (en)	1996-09-26	2005-02-10	Metabogal Ltd.	Cell/tissue culturing device, system and method
IL155588A0 (en)	2003-04-27	2003-11-23	Metabogal Ltd	Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
CN100410268C (zh)	1998-12-23	2008-08-13	博伊斯汤普生植物研究所	免疫原性的乙型肝炎表面抗原在转基因植物中的表达
US6642038B1 (en)	1999-09-14	2003-11-04	Genzyme Glycobiology Research Institute, Inc.	GlcNAc phosphotransferase of the lysosomal targeting pathway
US6770799B2 (en)	2000-03-17	2004-08-03	Thompson Boyce Plant Res	Expression of recombinant human acetylcholinesterase in transgenic plants
AU2001269923A1 (en) *	2000-06-19	2002-01-02	Genzyme Corporation	Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
US7138262B1 (en)	2000-08-18	2006-11-21	Shire Human Genetic Therapies, Inc.	High mannose proteins and methods of making high mannose proteins
WO2002018539A2 (en)	2000-08-25	2002-03-07	Lysometrix Corporation	Method for assaying the activity of lysosomal enzymes
US7001994B2 (en)	2001-01-18	2006-02-21	Genzyme Corporation	Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
US7723296B2 (en)	2001-01-18	2010-05-25	Genzyme Corporation	Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
DE60224816T2 (de)	2001-04-30	2009-01-22	ZyStor Therapeutics, Inc., Milwaukee	Subzelluläres targeting von therapeutischen proteinen
US7560424B2 (en)	2001-04-30	2009-07-14	Zystor Therapeutics, Inc.	Targeted therapeutic proteins
IES20011101A2 (en) *	2001-12-21	2003-06-25	Japkinstill Services Ltd	A Bi-directional Messaging System
US7658916B2 (en)	2002-04-05	2010-02-09	Genzyme Corporation	Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density
US7585518B2 (en)	2002-11-19	2009-09-08	Kimberly-Clark Worldwide, Inc.	Products and methods for maintaining or increasing ceramide levels in skin
US7388079B2 (en)	2002-11-27	2008-06-17	The Regents Of The University Of California	Delivery of pharmaceutical agents via the human insulin receptor
US7951557B2 (en)	2003-04-27	2011-05-31	Protalix Ltd.	Human lysosomal proteins from plant cell culture
EP1639085A2 (en)	2003-06-12	2006-03-29	Genzyme Corporation	Modified human acid sphingomyelinase having increased activity, and methods for making the same
US20050026823A1 (en) *	2003-06-20	2005-02-03	Biomarin Pharmaceutical Inc.	Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
US7442372B2 (en) *	2003-08-29	2008-10-28	Biomarin Pharmaceutical Inc.	Delivery of therapeutic compounds to the brain and other tissues
BRPI0416434A (pt)	2003-11-25	2007-02-21	Sinai School Medicine	métodos para aumentar a atividade de uma proteìna de ácido esfingomielinase (asm), para estender a meia-vida e prolongar a atividade de uma proteìna asm purificada, para aumentar a produção de uma proteìna asm recombinante através de uma célula hospedeira, e usos de uma composição de asm tipo alelo-selvagem, purificada e um composto análogo de ceramida ou esfingomielina, e de um composto análogo de ceramida ou de esfingomielina
US8119406B2 (en)	2004-10-13	2012-02-21	Protalix Ltd.	System and method for production of antibodies in plant cell culture
US7615224B2 (en)	2004-12-02	2009-11-10	Women's And Children's Hospital	Multiplex-bead complex for determination of lysosomal storage disorders
EP1960534A4 (en)	2005-12-15	2009-03-25	Univ New York State Res Found	ENZYMATIC METHODS FOR MEASURING THE SPHINGOMYLELIN AND PHOSPHATIDYLCHOLIN SHARE IN PLASMA AND TISSUE
AR059089A1 (es) *	2006-01-20	2008-03-12	Genzyme Corp	Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
WO2007091250A2 (en)	2006-02-06	2007-08-16	The Medical Research And Infrastructure Fund Of The Tel-Aviv Sourasky Medical Center	Enzyme replacement therapy for treating lysosomal storage diseases
SI1988823T1 (sl)	2006-02-09	2018-12-31	Genzyme Corporation	Počasna intraventrikularna dostava
CN101454347B (zh)	2006-02-13	2013-07-24	美国弗劳恩霍夫股份有限公司	流感抗原、疫苗组合物和相关方法
JP5302189B2 (ja)	2007-04-27	2013-10-02	長瀬産業株式会社	スフィンゴミエリナーゼ
US20110237538A1 (en)	2008-08-06	2011-09-29	Summit Corporation Plc	Treatment of lysosomal storage disorders and other proteostatic diseases
HUE044381T2 (hu)	2008-12-16	2019-10-28	Genzyme Corp	Szintetikus intermedierek oligoszacharid-fehérje konjugátumok elõállításához
PL2470199T3 (pl) *	2009-08-28	2019-11-29	Icahn School Med Mount Sinai	Enzymatyczna terapia zastępcza ze zwiększaniem dawki do leczenia niedoboru kwaśnej sfingomielinazy
US9155784B2 (en) *	2011-06-20	2015-10-13	Icahn School Of Medicine At Mount Sinai	Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders
US10022428B2 (en) *	2013-06-07	2018-07-17	Genzyme Corporation	Marker for acid sphingomyelinase disorders and uses thereof
BR112020003541A2 (pt) *	2017-08-24	2020-09-01	Sanofi	tratamento de condições ósseas anormais em pacientes com deficiência de esfingomielinase ácida

2010
- 2010-08-28 PL PL10812683T patent/PL2470199T3/pl unknown
- 2010-08-28 BR BR112012004377A patent/BR112012004377A2/pt not_active Application Discontinuation
- 2010-08-28 WO PCT/US2010/047057 patent/WO2011025996A2/en active Application Filing
- 2010-08-28 JP JP2012527054A patent/JP5955219B2/ja active Active
- 2010-08-28 KR KR1020237040891A patent/KR20230164773A/ko active Application Filing
- 2010-08-28 EP EP21200695.1A patent/EP3998078A1/en active Pending
- 2010-08-28 KR KR1020227023712A patent/KR102608551B1/ko active IP Right Grant
- 2010-08-28 US US12/870,790 patent/US8349319B2/en active Active
- 2010-08-28 RU RU2012111823/15A patent/RU2569744C2/ru active
- 2010-08-28 TR TR2019/11293T patent/TR201911293T4/tr unknown
- 2010-08-28 KR KR1020207008342A patent/KR20200034828A/ko not_active IP Right Cessation
- 2010-08-28 ES ES18199358T patent/ES2902229T3/es active Active
- 2010-08-28 KR KR1020127005293A patent/KR102094253B1/ko active IP Right Grant
- 2010-08-28 CN CN201610403228.4A patent/CN106047835A/zh active Pending
- 2010-08-28 CL CL2012000495A patent/CL2012000495A1/es unknown
- 2010-08-28 HR HRP20211992TT patent/HRP20211992T1/hr unknown
- 2010-08-28 SI SI201032100T patent/SI3482767T1/sl unknown
- 2010-08-28 SI SI201031915T patent/SI2470199T1/sl unknown
- 2010-08-28 MX MX2012002449A patent/MX356873B/es active IP Right Grant
- 2010-08-28 RU RU2015145255A patent/RU2731616C2/ru active
- 2010-08-28 AU AU2010286550A patent/AU2010286550B2/en active Active
- 2010-08-28 ES ES10812683T patent/ES2738859T3/es active Active
- 2010-08-28 CA CA2773133A patent/CA2773133A1/en active Pending
- 2010-08-28 DK DK10812683.0T patent/DK2470199T3/da active
- 2010-08-28 EP EP18199358.5A patent/EP3482767B1/en active Active
- 2010-08-28 IL IL300625A patent/IL300625B1/en unknown
- 2010-08-28 CN CN201610404696.3A patent/CN105999238A/zh active Pending
- 2010-08-28 PT PT10812683T patent/PT2470199T/pt unknown
- 2010-08-28 IL IL314807A patent/IL314807A/en unknown
- 2010-08-28 EP EP10812683.0A patent/EP2470199B1/en active Active
- 2010-08-28 PT PT181993585T patent/PT3482767T/pt unknown
- 2010-08-28 HU HUE10812683A patent/HUE046598T2/hu unknown
- 2010-08-28 LT LTEP18199358.5T patent/LT3482767T/lt unknown
- 2010-08-28 DK DK18199358.5T patent/DK3482767T3/da active
- 2010-08-28 KR KR1020217026374A patent/KR102608546B1/ko active IP Right Grant
- 2010-08-28 HU HUE18199358A patent/HUE057440T2/hu unknown
- 2010-08-28 LT LTEP10812683.0T patent/LT2470199T/lt unknown
- 2010-08-28 CN CN2010800439108A patent/CN102596232A/zh active Pending
- 2010-08-28 PL PL18199358T patent/PL3482767T3/pl unknown
2012
- 2012-02-26 IL IL218324A patent/IL218324B/en active IP Right Grant
- 2012-02-27 ZA ZA2012/01435A patent/ZA201201435B/en unknown
- 2012-11-16 US US13/679,583 patent/US8658162B2/en active Active
- 2012-11-16 US US13/679,623 patent/US8709408B2/en active Active
2014
- 2014-01-16 US US14/156,894 patent/US9114139B2/en active Active
2015
- 2015-07-08 US US14/793,838 patent/US9655954B2/en active Active
2016
- 2016-02-26 ZA ZA2016/01362A patent/ZA201601362B/en unknown
- 2016-03-03 JP JP2016041242A patent/JP6251307B2/ja active Active
- 2016-08-17 AU AU2016216625A patent/AU2016216625B2/en active Active
2017
- 2017-04-12 US US15/485,604 patent/US10188705B2/en active Active
- 2017-11-24 JP JP2017226255A patent/JP2018076322A/ja active Pending
2018
- 2018-06-12 AU AU2018204156A patent/AU2018204156B2/en active Active
- 2018-12-04 US US16/209,336 patent/US20190151419A1/en not_active Abandoned
2019
- 2019-05-27 IL IL266915A patent/IL266915B2/en unknown
- 2019-07-29 CY CY20191100808T patent/CY1122128T1/el unknown
- 2019-07-31 HR HRP20191385 patent/HRP20191385T1/hr unknown
2020
- 2020-01-17 JP JP2020005901A patent/JP6952810B2/ja active Active
- 2020-05-26 US US16/883,407 patent/US20210077593A1/en not_active Abandoned
- 2020-09-02 RU RU2020128994A patent/RU2020128994A/ru unknown
- 2020-10-13 AU AU2020256322A patent/AU2020256322B2/en active Active
2021
- 2021-09-28 JP JP2021157902A patent/JP7167281B2/ja active Active
2022
- 2022-02-18 US US17/675,474 patent/US20220305091A1/en active Pending
- 2022-10-26 JP JP2022171242A patent/JP7395693B2/ja active Active
- 2022-12-01 NO NO2022054C patent/NO2022054I1/no unknown
- 2022-12-08 HU HUS2200050C patent/HUS2200050I1/hu unknown
- 2022-12-15 FR FR22C1062C patent/FR22C1062I2/fr active Active
- 2022-12-20 NL NL301211C patent/NL301211I2/nl unknown
2023
- 2023-11-29 JP JP2023201609A patent/JP2024026214A/ja active Pending
2024
- 2024-02-20 AU AU2024201085A patent/AU2024201085A1/en active Pending

Also Published As

Publication number	Publication date
US8349319B2 (en)	2013-01-08
CL2012000495A1 (es)	2014-02-07
US20140335070A1 (en)	2014-11-13
PT3482767T (pt)	2021-12-29
BR112012004377A2 (pt)	2017-12-12
US20130078231A1 (en)	2013-03-28
DK2470199T3 (da)	2019-08-05
JP2018076322A (ja)	2018-05-17
US8658162B2 (en)	2014-02-25
AU2016216625B2 (en)	2018-07-05
TR201911293T4 (tr)	2019-08-21
HUS2200050I1 (hu)	2022-12-28
AU2018204156B2 (en)	2020-07-16
HUE057440T2 (hu)	2022-05-28
US20130078230A1 (en)	2013-03-28
EP3998078A1 (en)	2022-05-18
SI3482767T1 (sl)	2022-03-31
EP3482767A1 (en)	2019-05-15
KR20210107153A (ko)	2021-08-31
JP2022003065A (ja)	2022-01-11
US10188705B2 (en)	2019-01-29
RU2731616C2 (ru)	2020-09-07
AU2020256322A1 (en)	2020-11-12
CN106047835A (zh)	2016-10-26
JP6251307B2 (ja)	2017-12-20
JP5955219B2 (ja)	2016-07-20
RU2015145255A (ru)	2019-01-11
AU2018204156A1 (en)	2018-06-28
RU2015145255A3 (no)	2019-08-12
SI2470199T1 (sl)	2019-11-29
AU2016216625A1 (en)	2016-09-15
JP2020090513A (ja)	2020-06-11
HRP20191385T1 (hr)	2019-11-01
KR20230164773A (ko)	2023-12-04
WO2011025996A9 (en)	2011-08-25
IL266915B2 (en)	2023-07-01
JP2023012499A (ja)	2023-01-25
US20210077593A1 (en)	2021-03-18
EP2470199A2 (en)	2012-07-04
US9655954B2 (en)	2017-05-23
AU2024201085A1 (en)	2024-03-07
HRP20211992T1 (hr)	2022-04-01
US9114139B2 (en)	2015-08-25
RU2020128994A (ru)	2022-03-02
KR102094253B1 (ko)	2020-03-31
EP2470199A4 (en)	2013-03-27
IL300625B1 (en)	2024-09-01
KR102608551B1 (ko)	2023-12-04
CY1122128T1 (el)	2020-11-25
NL301211I2 (nl)	2023-02-02
IL314807A (en)	2024-10-01
IL266915B1 (en)	2023-03-01
JP2024026214A (ja)	2024-02-28
MX356873B (es)	2018-06-18
PT2470199T (pt)	2019-08-07
US20180055916A1 (en)	2018-03-01
RU2569744C2 (ru)	2015-11-27
PL3482767T3 (pl)	2022-02-14
HUE046598T2 (hu)	2020-03-30
RU2012111823A (ru)	2013-10-10
IL218324B (en)	2019-05-30
IL266915A (en)	2019-07-31
FR22C1062I1 (fr)	2023-02-03
JP7167281B2 (ja)	2022-11-08
WO2011025996A3 (en)	2012-03-15
IL300625A (en)	2023-04-01
ES2738859T3 (es)	2020-01-27
US8709408B2 (en)	2014-04-29
US20110052559A1 (en)	2011-03-03
US20190151419A1 (en)	2019-05-23
PL2470199T3 (pl)	2019-11-29
US20220305091A1 (en)	2022-09-29
NL301211I1 (nl)	2022-12-28
WO2011025996A2 (en)	2011-03-03
JP6952810B2 (ja)	2021-10-20
ZA201601362B (en)	2017-05-31
KR102608546B1 (ko)	2023-12-04
AU2010286550A1 (en)	2012-03-15
AU2010286550B2 (en)	2016-05-19
LT3482767T (lt)	2022-01-10
LT2470199T (lt)	2019-10-10
CN105999238A (zh)	2016-10-12
JP2013502933A (ja)	2013-01-31
EP2470199B1 (en)	2019-05-22
KR20200034828A (ko)	2020-03-31
IL218324A0 (en)	2012-04-30
DK3482767T3 (da)	2021-12-20
FR22C1062I2 (fr)	2023-12-29
US20160120957A1 (en)	2016-05-05
ES2902229T3 (es)	2022-03-25
ZA201201435B (en)	2020-05-27
CA2773133A1 (en)	2011-03-03
JP2016153408A (ja)	2016-08-25
CN102596232A (zh)	2012-07-18
KR20220104271A (ko)	2022-07-26
JP7395693B2 (ja)	2023-12-11
MX2012002449A (es)	2012-03-14
KR20120081077A (ko)	2012-07-18
EP3482767B1 (en)	2021-10-06
AU2020256322B2 (en)	2024-02-29

Publication	Publication Date	Title
NO2022054I1 (no)	2022-12-01	olipudase alfa
NL300973I2 (nl)	2022-05-05	Encorafenib
FIC20230032I1 (fi)	2023-11-02	Pegunigalsidaasi alfa
FIC20240027I1 (fi)	2024-07-30	efbemalenograstiimi alfa
DK2430035T3 (da)	2013-05-27	Uracylspipooxetannukleosider
BRPI1008827A2 (pt)	2016-02-23	deisobutenizador
BRPI1014968A2 (pt)	2016-12-13	subalargador
DE112009005323A5 (de)	2012-07-26	Hebelarmprüfmaschine
DE112009005462T8 (de)	2013-03-28	Lenkungsssteuervorrichtung
BR112012004964A2 (pt)	2016-04-05	girocóptero
BRPI1008070A2 (pt)	2016-03-15	tricianoboratos
DE112010004865T8 (de)	2013-01-24	Lamellennassreibkupplung
NO2018032I1 (no)	2018-09-14	velmanase alfa
BRPI1010159A2 (pt)	2016-03-29	bistuti
ES1070429Y (es)	2009-11-16	Traspaleta mejorada
BR112012003616A2 (pt)	2016-02-23	metilpirroloprimidinacarboxamidas
DE112010003843T8 (de)	2012-11-29	Lastansteuervorrichtung
UY3954Q (es)	2010-11-30	Epiladora
FI20095735A0 (fi)	2009-06-29	Puhdistinrakenne
FI20095490A0 (fi)	2009-04-30	Nahoituslaite
FIU20100011U0 (fi)	2010-01-08	Kulmakouruliitos
FR2949748B1 (fr)	2011-12-09	Bouee-balise
DE102009034429A8 (de)	2012-01-05	Flachantenne
ES1071420Y (es)	2010-05-20	Prelapida
AT506924A3 (de)	2010-11-15	Bauprojektor